English
Home > Products > CAS NO 372-38-3

China CAS NO 372-38-3 Factory

High quality Very first,and Shopper Supreme is our guideline to offer the most beneficial company to our clients.Nowadays, we're hoping our best to be certainly one of the top exporters in our area to satisfy consumers additional will need for CAS NO 372-38-3,372-38-3,1,3,5-Trifluorobenzene, Sincerely hope we're increasing up along with our buyers all around the entire world.
CAS NO 372-38-3, Our company mission is that providing high quality and beautiful products with reasonable price and strive to gain 100% good reputation from our clients. We believe Profession achieves excellence! We welcome you to cooperate with us and grow up together.

Related Products

Hot Products

  • N4-Benzoylcytosine

    N4-Benzoylcytosine

    Product Name:N4-Benzoylcytosine
    Molecular Formula:C11H9N3O2
    Molecular Weight:215.21
    CAS Registry Number:26661-13-2
  • 2,4,5-Trifluorobenzoic acid

    2,4,5-Trifluorobenzoic acid

    Product Name:2,4,5-Trifluorobenzoic acid
    Molecular Formula:C7H3F3O2
    Molecular Weight:176.09
    CAS Registry Number:446-17-3
  • Valeric acid

    Valeric acid

    Product Name:Valeric acid
    Molecular Formula:C5H10O2
    Molecular Weight;102.13
    CAS Registry Number;109-52-4
  • Nalmefene hydrochloride

    Nalmefene hydrochloride

    Product Name:Nalmefene hydrochloride
    Molecular Formula:C21H26ClNO3
    Molecular Weight;375.89
    CAS Registry Number;58895-64-0
  • Regorafenib hydrate

    Regorafenib hydrate

    Product Name:Regorafenib hydrate
    Molecular Formula:C21H17ClF4N4O4
    Molecular Weight;500.83
    CAS Registry Number;1019206-88-2
  • (R)-3-Aminopiperidine Dihydrochloride

    (R)-3-Aminopiperidine Dihydrochloride

    (R)-3-Aminopiperidine Dihydrochloride
    CAS NO:​334618-23-4
    Molecular Formula:C₅H₁₄Cl₂N₂
    Appearance:Off-White Solid
    Melting Point:206-208°C
    Molecular Weight:173.08
    Usage:Alogliptin Intermediates​
  • Related Blog
  • Reviews

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept